Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
Eur J Pediatr ; 183(5): 2375-2382, 2024 May.
Article in English | MEDLINE | ID: mdl-38446228

ABSTRACT

Although the mechanisms underlying the pathophysiology of long COVID condition are still debated, there is growing evidence that autonomic dysfunction may play a role in the long-term complications or persisting symptoms observed in a significant proportion of patients after SARS-CoV-2 infection. However, studies focused on autonomic dysfunction have primarily been conducted in adults, while autonomic function has not yet been investigated in pediatric subjects. In this study, for the first time, we assessed whether pediatric patients with long COVID present abnormalities in autonomic cardiac function. Fifty-six long COVID pediatric patients (mean age 10.3 ± 3.8 y) and 27 age-, sex-, and body surface area-matched healthy controls (mean age 10.4 ± 4.5y) underwent a standard 12-lead electrocardiography (ECG) and 24-h ECG Holter monitoring. Autonomic cardiac function was assessed by time-domain and frequency-domain heart rate variability parameters. A comprehensive echocardiographic study was also obtained by two-dimensional echocardiography and tissue Doppler imaging. Data analysis showed that pediatric patients with long COVID had significant changes in HRV variables compared to healthy controls: significantly lower r-MSSD (root mean square of successive RR interval differences, 47.4 ± 16.9 versus 60.4 ± 29.1, p = 0.02), significant higher values VLF (very low frequency, 2077.8 ± 1023.3 versus 494.3 ± 1015.5 ms, p = 0.000), LF (low frequency, 1340.3 ± 635.6 versus 354.6 ± 816.8 ms, p = 0.000), and HF (high frequency, 895.7 ± 575.8 versus 278.9 ± 616.7 ms, p = 0.000). No significant differences were observed between the two groups both in systolic and diastolic parameters by echocardiography.  Conclusion: These findings suggest that pediatric patients with long COVID have an imbalance of cardiac autonomic function toward a relative predominance of parasympathetic tone, as already reported in adult patients with long COVID. Further studies are needed to clarify the clinical significance of this autonomic dysfunction and demonstrate its role as a pathophysiological mechanism of long COVID, paving the way for effective therapeutic and preventive strategies. What is Known: • Long Covid in children has been described globally, but studies have mostly focused on collecting the temporal evolution of persisting symptoms. What is New: • Cardiac autonomic imbalance toward a relative predominance of parasympathetic tone is a mechanism underlying Long Covid in children, as also described in adults.


Subject(s)
Autonomic Nervous System , COVID-19 , Electrocardiography, Ambulatory , Heart Rate , Humans , Male , Female , Child , Case-Control Studies , COVID-19/physiopathology , COVID-19/complications , Adolescent , Heart Rate/physiology , Autonomic Nervous System/physiopathology , Post-Acute COVID-19 Syndrome , Heart/physiopathology , Electrocardiography , Echocardiography , SARS-CoV-2
2.
Ital J Pediatr ; 45(1): 167, 2019 Dec 19.
Article in English | MEDLINE | ID: mdl-31856879

ABSTRACT

BACKGROUND: Fetal alcohol spectrum disorder (FASD) refers to a broad spectrum of disabilities, in infants and children, resulting from moderate to excessive prenatal alcohol exposure. Significant associations with alcohol exposure were already reported with congenital structural heart defects: i.e. ventricular septal defects, atrial septal defects, conotruncal defects. CASES PRESENTATION: We describe two cases of children with FASD, both admitted to the Center for Rare Diseases and Birth Defects of Policlinico Universitario Agostino Gemelli, in whom asymptomatic cardiac rhythm alterations were detected in absence of structural cardiovascular system anomalies or cardiac channelopathies. CONCLUSIONS: No other reports about cardiac rhythm anomalies in individuals affected by FASD are actually available from the literature. We would like to make an alert for clinician, given the possibility of finding anomalies of heart conduction and rhythm in children affected by FASD even without structural congenital heart disease.


Subject(s)
Arrhythmias, Cardiac/diagnosis , Disability Evaluation , Electrocardiography, Ambulatory/methods , Fetal Alcohol Spectrum Disorders/diagnosis , Prenatal Exposure Delayed Effects/diagnosis , Arrhythmias, Cardiac/complications , Child , Electrocardiography/methods , Exercise Test/methods , Female , Fetal Alcohol Spectrum Disorders/etiology , Fetal Alcohol Spectrum Disorders/rehabilitation , Follow-Up Studies , Humans , Male , Monitoring, Physiologic/methods , Physical Examination/methods , Pregnancy , Severity of Illness Index , Time Factors
3.
Pediatr Med Chir ; 36(4): 90, 2014 Aug 31.
Article in English | MEDLINE | ID: mdl-25573706

ABSTRACT

Cutis Marmorata Telangiectatica Congenita (CMTC) is a rare, sporadic condition usually present at birth characterized by localized or generalized persistent cutis marmorata, telangiectasia and phlebectasia. We report a preterm female newborn, the third child of non-related caucasian parents, with CMTC at birth who showed typical cutaneous features and monolateral congenital glaucoma. The pathogenesis of this disorder is unknown and the cause is probably multifactorial. Teratogens and autosomal dominant mode of inheritance with incomplete penetrance have been considered as etiological factors. Prognosis, in uncomplicated cases, is good.


Subject(s)
Skin Diseases, Vascular/physiopathology , Telangiectasis/congenital , Female , Humans , Infant, Newborn , Livedo Reticularis , Prognosis , Skin Diseases, Vascular/etiology , Telangiectasis/etiology , Telangiectasis/physiopathology
4.
Article in English | MEDLINE | ID: mdl-24110209

ABSTRACT

The time-varying gradient fields generated during Magnetic Resonance Imaging (MRI) procedures have the potential to induce electrical current on implanted endocardial leads. Whether this current can result in undesired cardiac stimulation is unknown. This paper presents an optically coupled system with the potential to quantitatively measure the currents induced by the gradient fields into endocardial leads during MRI procedures. Our system is based on a microcontroller that works as analog-to-digital (A/D) converter and sends the current signal acquired from the lead to an optical high-speed light-emitting-diode transmitter. Plastic fiber guides the light outside the MRI chamber, to a photodiode receiver and then to an acquisition board connected to a PC. The preliminary characterization of the performances of the system is also presented.


Subject(s)
Defibrillators, Implantable , Pacemaker, Artificial , Artifacts , Humans , Magnetic Fields , Magnetic Resonance Imaging , Optical Devices
5.
Phys Med Biol ; 58(15): 5301-16, 2013 Aug 07.
Article in English | MEDLINE | ID: mdl-23863617

ABSTRACT

The aim of this study is to propose setups for in vitro assessment of RFID (radiofrequency identification) interference on pacemakers (PM). The voltage induced at the input stage of the PM by low-frequency (LF) and high-frequency (HF) RFID transmitters has been used to quantify the amount of the interference. A commercial PM was modified in order to measure the voltage at its input stage when exposed to a sinusoidal signal at 125 kHz and 13.56 MHz. At both frequencies, two antennas with different dimensions (diameter = 10 cm and 30 cm, respectively) were used to generate the interfering field, and the induced voltage was measured between the lead tip and the PM case (unipolar voltage), and between the tip and ring electrodes (bipolar voltage). The typical lead configurations adopted in similar studies or proposed by international standards, as well as lead paths closer to actual physiological implants were tested. At 125 kHz, the worst-case condition differs for the two antennas: the 10 cm antenna induced the highest voltage in the two-loop spiral configuration, whereas the 30 cm antenna in the 225 cm(2) loop configuration. At 13.56 MHz, the highest voltage was observed for both the antennas in the 225 cm(2) loop configuration. Bipolar voltages were found to be lower than the unipolar voltages induced in the same configurations, this difference being not as high as one could expect from theoretical considerations. The worst-case scenario, in terms of the induced voltage at the PM input stage, has been identified both for LF and HF readers, and for two sizes of transmitting antennas. These findings may provide the basis for the definition of a standard implant configuration and a lead path to test the EMI effects of LF and HF RFID transmitters on active implantable devices.


Subject(s)
Pacemaker, Artificial , Radio Frequency Identification Device , Electromagnetic Phenomena , Prostheses and Implants
6.
Pediatr Med Chir ; 33(4): 199-202, 2011.
Article in English | MEDLINE | ID: mdl-22423481

ABSTRACT

Pasteurella multocida is normally present in respiratory and digestive tract of many domestic and wild animals, but is a rare pathogen in neonatal infection. Here we describe for the first time a case of meningitis complicated by status epilepticus and right parietal lobe cerebritis. The patient showed a dramatic clinical onset characterized by septic appearance and prolonged seizures. Multidrug anticonvulsivant therapy was used to control the status epilepticus, but despite the aggressive treatment electrical crises were still evident 24 hours after the admission. Furthermore, a brain MRI, performed to investigate a persistent intermittent fever even if CSF became sterile, showed a focus cerebritis in the right parietal lobe, early stage of the cerebral abscess. Prolonged antibiotic therapy with steroids was requested to solve the cerebritis area. Interestingly, direct contact between the patient and domestic animals was denied by the family, but the father reported a contact with a rooster, killed and cooked few days before, suggesting, as previously described, that Pasteurella may also be transmitted through asymptomatic human carrier. The patient had a favourable outcome with no medium-term sequelae one month after discharge, but the severity of the clinical course and the unpredictable way of transmission highlight the importance of hygiene measures approaching infants.


Subject(s)
Bacteremia/complications , Brain Abscess/microbiology , Meningitis/microbiology , Pasteurella Infections/complications , Pasteurella multocida , Status Epilepticus/microbiology , Animals , Anti-Bacterial Agents/therapeutic use , Anticonvulsants/therapeutic use , Bacteremia/diagnosis , Bacteremia/drug therapy , Brain Abscess/diagnosis , Brain Abscess/drug therapy , Drug Therapy, Combination , Glucocorticoids/therapeutic use , Humans , Infant, Newborn , Male , Meningitis/diagnosis , Meningitis/drug therapy , Pasteurella Infections/diagnosis , Pasteurella Infections/drug therapy , Pasteurella multocida/isolation & purification , Poultry , Rare Diseases , Status Epilepticus/drug therapy , Treatment Outcome
7.
Pediatr Med Chir ; 30(6): 281-9, 2008.
Article in Italian | MEDLINE | ID: mdl-19431950

ABSTRACT

The frequency of early-onset neonatal sepsis without prophylaxis is 1-5/1.000 live births. Since year '70 the most frequent causative microorganism is the group B Streptococcus (S. agalactiae, GBS), followed by Escherichia coli. The mortality rate is now reduced to 4% due to the improvement of neonatal intensive care. In the USA, the incidence of GBS early-onset neonatal sepsis has been markedly reduced by the application of the guidelines released by the Centers for Disease Control (CDC). This strategy, however, is not effective on occurrence of late-onset neonatal group B streptococcal disease. In Italy, the application of CDC guidelines is not customary, and different, often complex, protocols of obstetrical-neonatological integrated approach are applied. The frequency of infectious risk has made the GBS a paramount problem for the neonatologist, even for the legal responsibility issues resulting from the multiplicity of possible options. To reach the best level of protection of the newborn against early-onset GBS infection, the working group of providers of prenatal, obstetric, and neonatal care of the functional area of Cuneo issued an integrated protocol, in order to perform the GBS screening with the optimal culture method suggested by CDC guidelines in the highest possible number of pregnant women, and to standardize the obstetrical and neonatal management.


Subject(s)
Pregnancy Complications, Infectious/diagnosis , Streptococcal Infections/prevention & control , Streptococcus agalactiae , Adult , Age Factors , Algorithms , Anti-Bacterial Agents/pharmacology , Clindamycin/pharmacology , Clinical Protocols , Erythromycin/pharmacology , Female , Humans , Infant, Newborn , Intensive Care, Neonatal , Italy , Microbial Sensitivity Tests , Practice Guidelines as Topic , Pregnancy , Prevalence , Rectum/microbiology , Risk Factors , Streptococcal Infections/diagnosis , Streptococcal Infections/epidemiology , Streptococcal Infections/mortality , Streptococcal Infections/transmission , Streptococcus agalactiae/drug effects , Streptococcus agalactiae/isolation & purification , United States , Vagina/microbiology
8.
Rheumatol Int ; 28(1): 73-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17564712

ABSTRACT

Unilateral cervical mass and fever were firstly misdiagnosed as bacterial lymphadenitis in a 6-year-old child and empirically treated with antibiotics. Later the child developed the additional features of Kawasaki syndrome and received intravenous immunoglobulins at the eighth day since fever onset with progressive disappearance of the cervical mass and no cardiac sequel. Kawasaki syndrome should be considered in childhood as a relevant cause of cervical lymphadenopathy unresponding to antibiotics: its recognition at an early stage might contribute to anticipate a proper treatment and abate heart complication rate.


Subject(s)
Diagnostic Errors , Lymphadenitis/diagnosis , Mucocutaneous Lymph Node Syndrome/diagnosis , Child , Diagnosis, Differential , Humans , Male , Mucocutaneous Lymph Node Syndrome/diagnostic imaging , Ultrasonography
9.
Pediatr Cardiol ; 26(4): 440-3, 2005.
Article in English | MEDLINE | ID: mdl-16374694

ABSTRACT

Chylothorax (KT) may be a complication of thoracic surgery. Its management is not well established and may comprise dietary interventions and surgery. The effectiveness of somatostatin and its analogues has been reported, although their mechanism(s) of action is unclear. We report our experience with octreotide in a series of patients with postoperative chylothorax. Eight patients with KT were treated with a continuous intravenous infusion of octreotide (OCT) at a starting dose of 0.5 microg/kg/hr. They were compared with four additional patients with KT who were treated according to the conventional approach. After a mean of 3.3 +/- 1.9 days of treatment, fluid discharge diminished dramatically. In all patients, fluid losses stopped by postoperative day 10.5 +/- 2.9 and chest tubes could be removed after 12.8 +/- 4.1 days. Compared to a small group of historical controls, OCT reduced significantly the total fluid losses (141.1 +/- 89.3 vs 396.7 +/- 151.0 ml/kg; p = 0.003) and the postoperative length of stay (p = 0.05). No patients in the group treated with OCT required parenteral nutrition (compared to all four of the controls; p = 0.002) and/or thoracenteses (compared to two of four controls). In postoperative KT, OCT seems to be at least as effective as the conventional approach. Furthermore, OCT may reduce total fluid losses and postoperative length of stay. This may have a beneficial effect on the risk of complications and on hospital costs.


Subject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Chylothorax/drug therapy , Octreotide/therapeutic use , Thoracic Surgical Procedures/adverse effects , Antineoplastic Agents, Hormonal/administration & dosage , Child , Child, Preschool , Chylothorax/etiology , Female , Follow-Up Studies , Humans , Infant , Infusions, Intravenous , Length of Stay , Male , Octreotide/administration & dosage , Postoperative Complications , Prospective Studies , Treatment Outcome
11.
Farmaco ; 59(12): 945-52, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15598429

ABSTRACT

The synthesis of some aroylisothiosemicarbazides was accomplished and their biological activity against bacteria, fungi, and mycobacteria was investigated. Different synthetic pathways were followed according to the kind of substituents that were introduced on both the aroyl ring and the sulfur atom. Anti-bacterial activity was measured against Staphylococcus aureus, S. epidermidis, Streptococcus agalactiae and S. faecalis, Escherichia coli, and Salmonella typhi, while antifungal activity was evaluated against C. albicans. Two species, Mycobacterium tuberculosis H37RV and Mycobacterium avium ATCC19421, were employed to evaluate antimycobacterial activity.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Semicarbazides/chemical synthesis , Semicarbazides/pharmacology , Drug Evaluation, Preclinical/methods , Microbial Sensitivity Tests/methods
12.
Heart ; 90(12): 1467-70, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15547030

ABSTRACT

OBJECTIVES: To analyse safety, efficacy, and follow up results of percutaneous closure of persistent ductus arteriosus (PDA) in very young symptomatic children. PATIENTS AND DESIGN: Between March 2000 and March 2003, of 197 patients treated at the authors' institution 18 were symptomatic children aged < or = 3 years old. Seven of these children were < or = 1 year old. Indications for closure were failure to thrive (12 patients) and frequent respiratory infections (six patients). The procedure was carried out under heavy sedation with fluoroscopic control. The Amplatzer duct occluder device was used. Basal physical examinations and echocardiograms were performed before the procedure and at follow up (three, six, and 12 months and yearly thereafter). RESULTS: Mean (SD) age was 18.3 (10) months and mean (SD) weight at closure was 9.1 (2.2) kg. Neither death nor any major complications occurred. Complications occurred in three patients aged < or = 1 year. Two patients had a mild inguinal haematoma. One patient had femoral artery thrombosis that was successfully treated by intravenous urokinase. The mean (SD) follow up was 12.8 (8.5) months. No problems occurred. Patients with recurrent respiratory infections had no significant recurrences and children who had failed to thrive had significantly increased growth. CONCLUSIONS: In experienced hands, percutaneous closure of moderate to large PDA in very young symptomatic children is safe, effectively closes the PDA, and solves clinical problems.


Subject(s)
Balloon Occlusion/instrumentation , Ductus Arteriosus, Patent/therapy , Balloon Occlusion/adverse effects , Cardiac Catheterization/methods , Child, Preschool , Ductus Arteriosus, Patent/complications , Failure to Thrive/etiology , Failure to Thrive/therapy , Female , Humans , Infant , Male , Prosthesis Design , Respiratory Tract Infections/etiology , Respiratory Tract Infections/prevention & control , Treatment Outcome
13.
Arch Pediatr ; 11(8): 936-9, 2004 Aug.
Article in French | MEDLINE | ID: mdl-15288086

ABSTRACT

Neonatal Lupus Syndrome is a rare disease caused by placental passage of maternal autoantibodies. Pathogenesis is partially unknown and many clinical manifestations are possible. We report on newborn siblings who presented with different symptoms of Neonatal Lupus Syndrome. One patient presented with congenital heart block and another with hepatic and haematologic involvement. Cases of Neonatal Lupus among siblings are very rare, because of the high risk of pregnancy in affected women. Various clinical expressions may be explained by a different specificity of Anti-Ro autoantibodies among siblings. The reported cases are commented with regard to recent literature, trying to explain their pathogenesis.


Subject(s)
Lupus Erythematosus, Systemic/congenital , Lupus Erythematosus, Systemic/diagnosis , Pregnancy Complications/diagnosis , Abortion, Spontaneous/etiology , Antibody Specificity , Autoantibodies/blood , Autoantibodies/immunology , Autoantigens , Electrocardiography , Enzyme-Linked Immunosorbent Assay , Female , Heart Block/congenital , Heart Block/diagnosis , Hematologic Diseases/congenital , Humans , Infant, Newborn , Liver Diseases/congenital , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/immunology , Male , Maternal-Fetal Exchange , Pedigree , Perinatal Care , Pregnancy , Pregnancy Complications/drug therapy , Pregnancy Complications/immunology , Prenatal Care , Ribonucleoproteins/immunology , SS-B Antigen
15.
Farmaco ; 56(8): 549-54, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11601639

ABSTRACT

9,10-Anthracenedione derivatives are known to exhibit a quite potent anticancer activity. It has also been reported that these compounds can be effectively employed in both antibacterial and antitrypanosomal therapy. Anthraquinones also exhibit some undesirable side effects, like cardiotoxicity. So many interactions seem to demonstrate that 9,10-anthracenediones strongly interact with a number of biological sites. In this paper we wish to report on the synthesis and the pharmaceutical activity of some newly synthesised derivatives containing the anthraquinone pharmacophore.


Subject(s)
Anthraquinones/chemical synthesis , Anti-Infective Agents/chemical synthesis , Anthraquinones/pharmacology , Anti-Infective Agents/pharmacology , Microbial Sensitivity Tests , Structure-Activity Relationship
16.
Eur J Pediatr ; 159(5): 364-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10834523

ABSTRACT

UNLABELLED: This study was aimed at evaluating the efficacy of ibuprofen in the prophylaxis of patent ductus arteriosus (PDA) in very preterm neonates and at detecting eventual side-effects. A total of 46 preterm neonates with gestational age under 31 weeks were randomly assigned at 2 h of life: 23 to the prophylaxis group and 23 to the control group. The prophylaxis group received intravenous treatment with ibuprofen lysine (10 mg/kg), followed by 5 mg/kg after 24 h and 48 h. No placebo was given to the control group. No PDA was demonstrated at 72 h of life in 20 of the 23 babies in the ibuprofen group (87%) nor in 7 of the 23 control neonates (30.4%). All neonates with PDA received treatment with indomethacin. One neonate in the prophylaxis group and three in the control group underwent surgical ligation. Prophylaxis with ibuprofen was not associated with any significant side-effect except for food intolerance. CONCLUSION: Ibuprofen prophylaxis seems to be efficient in closing patent ductus arteriosus and in reducing indomethacin treatment. No significant early side-effects were found due to ibuprofen.


Subject(s)
Ductus Arteriosus, Patent/prevention & control , Ibuprofen/therapeutic use , Infant, Premature , Ductus Arteriosus, Patent/therapy , Female , Humans , Ibuprofen/adverse effects , Indomethacin/therapeutic use , Infant, Newborn , Infusions, Intravenous , Male
17.
Clin Pharmacol Ther ; 67(6): 676-83, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10872650

ABSTRACT

OBJECTIVE: To evaluate the effects on cerebral and renal blood flow velocities of ibuprofen when used as prophylaxis for patent ductus arteriosus in preterm neonates (gestational age <30 weeks). METHODS: Blood flow velocities in the anterior cerebral artery and the renal artery were measured with Doppler ultrasonography in 17 neonates before, during, and 10, 30, and 60 minutes after administration of 10 mg/kg ibuprofen lysine. RESULTS: In four (23.6%) neonates without echocardiographic patency of the ductus, no significant modifications in blood flow velocities and Doppler indexes were found either in the anterior cerebral artery or in the renal artery. In 13 (76.4%) neonates, cardiac echocardiographic Doppler showed patency of the ductus and left-to-right shunt. In these neonates diastolic and mean blood velocities rapidly increased both in the anterior cerebral artery and the renal artery (P < .0001). Resistance and pulsatility index decreased during the study period (P < .0001 and P < .001, respectively, in the anterior cerebral artery; P < .0001 in the renal artery). CONCLUSIONS: Data suggest that ibuprofen does not determine any direct effect on cerebral and renal blood flow velocities; hemodynamic modifications observed in neonates with patency of ductus can be related to closure of the ductus induced by the drug.


Subject(s)
Cerebrovascular Circulation/drug effects , Ductus Arteriosus, Patent/prevention & control , Ibuprofen/pharmacology , Infant, Premature , Renal Circulation/drug effects , Blood Flow Velocity/drug effects , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/physiopathology , Echocardiography, Doppler , Female , Gestational Age , Humans , Ibuprofen/therapeutic use , Infant, Newborn , Male , Prospective Studies , Treatment Outcome
18.
Farmaco ; 55(2): 93-8, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10782378

ABSTRACT

Arylidenimidazoles bearing a thioethereal function in the position 2 of the imidazole ring show good antimicrobial activity. We now report on the synthesis and the biological properties of some novel arylidenisothiosemicarbazones, structurally related to the arylideneiminoimidazoles of which they can be considered the linear precursors. Particular attention has been put on the influence of structural modifications on the biological activity.


Subject(s)
Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/pharmacology , Antifungal Agents/chemical synthesis , Antifungal Agents/pharmacology , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/pharmacology , Anti-Infective Agents/chemistry , Chemistry, Pharmaceutical , Microbial Sensitivity Tests , Structure-Activity Relationship , Thiosemicarbazones/chemistry
19.
J Pediatr Hematol Oncol ; 21(4): 303-5, 1999.
Article in English | MEDLINE | ID: mdl-10445894

ABSTRACT

An infant with Kawasaki syndrome presenting with fever, rash, and a high percentage of neutrophils with toxic granulation is reported. The peripheral blood smears of the patient showed a high proportion of neutrophils with marked vacuoles and toxic granulations. The reactive changes in neutrophils could be helpful in the early detection of the disease, especially in infants younger than 6 months of age who are at high risk for development of coronary artery disease.


Subject(s)
Mucocutaneous Lymph Node Syndrome/pathology , Neutrophils/pathology , Diagnosis, Differential , Female , Humans , Immunoglobulin G/therapeutic use , Immunoglobulins, Intravenous/therapeutic use , Infant , Mucocutaneous Lymph Node Syndrome/therapy , Time Factors
20.
Minerva Pediatr ; 50(4): 111-9, 1998 Apr.
Article in Italian | MEDLINE | ID: mdl-9808963

ABSTRACT

OBJECTIVES: To examine left ventricular function in patients previously treated with anthracycline for childhood malignancies. To evaluate the importance of age at the beginning of therapy, of total cumulative dose and of length of follow-up on late cardiac effects of anthracyclines. DESIGN: Cross sectional echocardiography study of left ventricular function. PATIENTS: Eighteen patients surviving between 1 and 9 years (median 2 years) from end of chemotherapy. Cumulative doses were between 120 and 550 mg/mq (median 275 mg/mq). Age at the beginning of chemotherapy was between 1.8 and 12.25 years (median 5.17 years). Nineteen healthy subjects were also studied as control group. METHODS: Assessment of transmitral diastolic pulsed wave Doppler flow patterns and of transaortic pulsed wave Doppler flow patterns. Evaluation of systolic function measured by M-mode echocardiography. RESULTS: Patients compared to controls showed a significative reduction of Ejection Fraction, of Shortening Fraction, of peak early phase to peak atrial phase filling velocity ratio and an increase of peak atrial phase filling velocity and of time-velocity integral of peak filling atrial phase. These alterations were more evident at doses higher than 250 mg/m2, in patients whose therapy started before 5 years of age and in patients whose follow-up was longer than 5 years. CONCLUSIONS: Significant abnormalities of systolic and diastolic function may appear some years after the end of anthracycline therapy for childhood malignancies. Therefore patient's continued follow-up is necessary in order to guide patient care and to better chemotherapeutic protocols.


Subject(s)
Anthracyclines/adverse effects , Heart/drug effects , Age Factors , Child , Child, Preschool , Cross-Sectional Studies , Data Interpretation, Statistical , Diastole/drug effects , Echocardiography , Female , Follow-Up Studies , Humans , Infant , Male , Neoplasms/drug therapy , Systole/drug effects , Time Factors , Ventricular Function, Left/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...